Hum. Reprod. Advance Access originally published online on January 29, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Reproduction, Vol. 19, No. 3, 670-675,
March 2004
© 2004 European Society of Human Reproduction and Embryology
Derivation of a diploid human embryonic stem cell line from a mononuclear zygote
1 Department of Obstetrics and Gynecology, Rambam Medical Center, POB 9602, Haifa 31096, 2 Biotechnology-Interdisciplinary Unit and 3 Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
4 To whom correspondence should be sent. e-mail: Itskovitz{at}rambam.health.gov.il
| Abstract |
|---|
|
|
|---|
BACKGROUND: IVF occasionally produces aneuploid zygotes with one or three pronuclei (PN). Routinely, these zygotes are discarded. The aim of this work was to establish human embryonic stem cell (hESC) lines from blastocysts resulting from abnormal fertilization. METHODS: Abnormally fertilized zygotes were cultured to the blastocyst stage and, following zona pellucida digestion, zona-free blastocysts were placed on a mouse feeder layer. Culture of hESCs was carried out as described earlier. RESULTS: Six out of the nine developing blastocysts attached to the feeder layer. One hESC line, originating from a mononuclear zygote following ICSI, was successfully derived. This line displayed typical phenotype and embryonic surface markers, and exhibited the potential to develop into all three embryonic germ layers both in vitro (by embryoid body formation) and in vivo (teratoma generation). Genetic examination revealed normal diploid karyotype and heterozygotic appearance for metachromatic leukodystrophy (MLD). CONCLUSION: This method, which requires neither immuno nor mechanical removal of the trophectoderm, may facilitate the derivation of hESC lines in general, and those from abnormal embryos in particular. Furthermore, it is shown that aneuploid zygotes can be used as a source for normal hESC derivation and hold the potential to generate aneuploid hESC lines for research purposes.
Key words: aneuploid zygote/derivation/differentiation/embryonic stem cells
| Introduction |
|---|
|
|
|---|
Normal human zygotes consist of two pronuclei representing each parent. However, IVF often results in abnormal zygotes with one or three pronuclei (PN). The high percentage of diploid embryos which was reported to develop from IVF 1PN zygotes (Munne et al., 1993
At the blastocyst stage, the embryo forms an inner cell mass (ICM) capable of forming a wide range of cell types of the body, and an outer trophectoderm, which is committed to form part of the placenta (Winkel and Pedersen, 1998
). Isolation and seeding of the ICM on an appropriate feeder layer may generate human embryonic stem cells (hESCs) (Thomson et al., 1998
; Reubinoff et al., 2000
). Such isolation can be accomplished by removal of the trophectoderm either mechanically (Amit and Itskovitz-Eldor, 2002
) or by immunosurgery (Thomson et al., 1998
; Reubinoff et al., 2000
; Lanzendorf et al., 2001
; Amit and Itskovitz-Eldor, 2002
). All hESCs have the ability to self-renew perpetually in culture and maintain undifferentiated phenotype and normal karyotype. They are pluripotent, i.e. capable of developing into all three primary germ layer derivatives, namely ectoderm, mesoderm and endoderm, both in vitro and in vivo [embryoid body (EB) and teratoma formation, respectively] (Draper and Andrews, 2002
). To date, blastocysts used for hESC derivation have been obtained from donated normal embryos (Thomson et al., 1998
; Reubinoff et al., 2000
; Lanzendorf et al., 2001
; Amit and Itskovitz-Eldor, 2002
) or from poor-quality discarded embryos (Mitalipova et al., 2003
). This work aimed at deriving hESCs from non-usable aneuploid zygotes. As it was reported that mouse ES cells can be derived by simply culturing the blastocyst on the feeder layer (Nagy et al., 2003
), this was also examined in the human.
| Materials and methods |
|---|
|
|
|---|
Blastocyst culture
Discarded zygotes were donated to this study by couples undergoing IVF at Rambam Medical Center who signed consent forms. Zygotes (n = 60) were cultured to the blastocyst stage according to our IVF laboratory standard protocol: drops under oil using Cook media (Cook, Queensland, Australia) for insemination, growth and blastocyst stage (Cook IM, GM and BM, respectively).
hESC derivation and cultivation
After zona pellucida digestion by Tyrodes acidic solution (Sigma, St Louis, MO), whole blastocysts were placed on mitotically inactivated mouse embryonic fibroblasts (MEFs). Cells were grown, passaged, frozen and thawed as previously described (Thomson et al., 1998
; Amit and Itskovitz-Eldor, 2002
).
EB and teratoma formation, genetic characterization and histological sections
All hESC characterizations were done as previously described (Amit et al., 2003
). Mutation of metachromatic leukodystrophy (MLD) was detected using DNA which was isolated from cells of the newly derived cell line, by mutation-specific PCR. The analysis was performed by the Genetic Unit at Hadassah University Hospital, Ein-Karem, Jerusalem, Israel and by the Developmental Biology Unit, Department of Obstetrics and Gynaecology, Rambam Medical Center, Haifa, Israel.
Immunofluorescence and confocal microscopy
Cultured colonies or attached EBs were fixed in situ with 4% paraformaldehyde (Sigma) in phosphate-buffered saline (PBS; Gibco, San Diego, CA) for 30 min at room temperature. After blocking with 10% serum, the cells were stained with one of the following primary antibodies: anti-stage-specific embryonic antigen 3 (SSEA3) or 4 (SSEA4), anti-tumour rejection antigen (TRA) 160 and 181, all kindly provided by Professor P.Andrews, University of Sheffield, UK), anti-CD31 (Dako, Denmark) and anti-cytokeratin 17 and anti-tubulin
III isoform (both from Chemicon International, Temecula CA). Cells were then rinsed three times with PBS (Gibco) and incubated for 30 min with a suitable fluorescein isothiocyanate (FITC)- or Cy3-conjugated secondary antibody (Sigma). 4',6-Diamidino-2-phenylindole (DAPI) or propidium iodide (PI) (Sigma) was added (1:1000) to the last rinse. The immunolabelled cells were examined using either fluorescence microscopy (Carl Zeiss, Jena, Germany) or a confocal laser scanning system (BioRad Laboratories Ltd, Hertfotdshire, UK).
| Results |
|---|
|
|
|---|
Blastocyst culture
Applying our standard protocol for blastocyst culture, most aneuploid zygotes failed to develop into blastocysts. The nine out of 60 zygotes that developed into blastocysts consisted of seven 3PN and two 1PN. These zygotes showed either typical blastocyst morphology or irregular blastocyst morphology, i.e. large peripheral cells and an unclear ICM.
hESC line derivation and cultivation
Zona pellucida was digested and blastocysts were placed on a mitotically inactivated mouse feeder layer (Figure 1A). Within 24 h, six out of the nine blastocysts attached to the feeder layer (Figure 1B). The trophectoderm was immersed within the feeder layer and ceased to proliferate. In contrast, after several days, small tightly packed cells began to proliferate from four clumps. Each of the small colonies was mechanically dissociated, divided into two and replaced on a fresh feeder layer. A few days later, the same procedure was repeated. Most isolated ICM clumps died out after two or three passages, leaving a single ICM colony which continued to proliferate and propagate. Consequently, one hESC line was established (Figure 1C). The line, designated I9, exhibited normal growth rate, was passaged for >40 passages and survived freeze and thaw cycles.
|
hESC line characterization
Characterization of the derived line was conducted according to the following parameters.
Morphology. The I9 line continued to proliferate and maintained a morphology typical of hESC colonies, i.e. round colonies with sharp edges (Figure 2A), in which the spaces between cells are clear (Figure 2B). Single cell morphology showed a high nucleus to cytoplasm ratio with the presence of at least two nucleoli (Figure 2C).
|
Genetic analyses. Karyotype analyses were performed on 66 cells from passages 27 and 29. Both analyses revealed normal human karyotype (46,XX). Two examples of the examined chromosomes are shown in Figure 3. As the line was donated by a patient undergoing preimplantation genetic diagnostic (PGD) treatment, analysis for the specific MLD mutation was also performed. DNA was extracted at passages 10 and 24. The line was found to be heterozygous to the disease.
|
Embryonic markers. The hESC line grown for 32 passages was found to stain positive for typical primate ES cell surface markers (Thomson et al., 1998
) SSEA4, TRA-160 and TRA-181 (Figure 4), and weakly positive for SSEA3.
|
EB formation in vitro. Similarly to other hESCs, once removed from its feeder layer and cultured in suspension (Itskovitz-Eldor et al., 2000
) (Figure 5A), line I9 formed EBs, including cystic ones (Figure 5B). Stem cells within these EBs differentiated into various cell types (Figure 5C).
|
The developmental potential of line I9 was examined by expression of representatives of the three germ layers in 10- to 15-day-old EBs. Formation of blood vessel-like structures (Figure 6A), neuron generation (Figure 6B) and epithelial cell sheets expressing low molecular weight cytokeratins (Figure 6C) were indicative of mesoderm, ectoderm and endoderm, respectively.
|
Teratoma generation in vivo. Injection of undifferentiated I9 cells into the hind limb muscle of a SCID-beige mouse resulted in the generation of a teratoma which possessed representatives of all three germ layers (Figure 7).
|
| Discussion |
|---|
|
|
|---|
Blastocysts developed from aneuploid zygotes may exhibit atypical morphology in which it is difficult to identify an ICM zone, with a clear distinction between the ICM and trophectoderm. Using a method where whole blastocysts were placed on inactivated MEFs produced a successful attachment rate (six out of nine) and the proliferation of pluripotent clumps. This method has already been used in the isolation of mouse ICM (Nagy et al., 2003
| Acknowledgements |
|---|
We thank the IVF team at Rambam Medical Center and Dr Hanna Segev for embryo and MLD analysis, Anna Ziskind and Ludmilla Mazor for technical assistance, Ofer Shenker for confocal assistance, and Hadas ONeill for editing. We thank the Fund for Medical Research and Development of Infrastructure and Health Services, Rambam Medical Center and the Technion Research and Development Foundation Ltd which supported this work.
| References |
|---|
|
|
|---|
Amit M and Itskovitz-Eldor J (2002) Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200,225232.[CrossRef][Web of Science][Medline]
Amit M, Margulets V, Segev H, Shariki C, Laevsky I, Coleman R and Itskovitz-Eldor J (2003) Human feeder layers for human embryonic stem cells. Biol Reprod 68,21502156.
Draper JS and Andrews PW (2002) Embryonic stem cells: advances toward potential therapeutic use. Curr Opin Obstet Gynecol 14,309315.[CrossRef][Web of Science][Medline]
Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H and Benvenisty N (2000) Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Mol Med 6,8895[journal not in library; checked e-journal].[Web of Science][Medline]
Lanzendorf SE, Boyd CA, Wright DL, Muasher S, Oehninger S and Hodgen GD (2001) Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil Steril 76,132137.[CrossRef][Web of Science][Medline]
Mitalipova M, Calhoun J, Shin S, Wininger D, Schulz T, Noggle S, Venable A, Lyons I, Robins A, Stice S (2003) Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21(5):521526.
Munne S, Tang YX, Grifo J and Cohen J (1993) Origin of single pronucleated human zygotes. J Assist Reprod Genet 10,276279.[CrossRef][Web of Science][Medline]
Nagy A, Gertsensten M, Vintersten K and Behringer R (2003) De novo isolation of ES cell lines from blastocysts. In Hogan B, Beddington R, Costantini F, Lacy E (eds), Manipulating the Mouse Embryo: A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 380383.
Reubinoff B, Pera M, Fong C, Trounson A and Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnol 18,399404.[CrossRef][Web of Science][Medline]
Staessen C and Van Streirteghem AC (1997) The chromosomal constitution of embryos developing from abnormally fertilized oocytes after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod 12,321327.
Sultan KM, Munne S, Palermo GD, Alikani M and Cohen J (1995) Chromosomal status of uni-pronuclear human zygotes following in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod 10,132136.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282,11451147.
Winkel GK and Pedersen RA (1998) Fate of the inner cell mass in mouse embryos as studied by microinjection of lineage tracers. Dev Biol 127,143156.
Submitted on May 6, 2003; resubmitted on August 14, 2003; accepted on December 4, 2003.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Raya, I. Rodriguez-Piza, B. Aran, A. Consiglio, P.N. Barri, A. Veiga, and J.C. Izpisua Belmonte Generation of Cardiomyocytes from New Human Embryonic Stem Cell Lines Derived from Poor-quality Blastocysts Cold Spring Harb Symp Quant Biol, November 26, 2008; (2008) sqb.2008.73.038v2. [Abstract] [PDF] |
||||
![]() |
C. Allegrucci and L.E. Young Differences between human embryonic stem cell lines Hum. Reprod. Update, March 1, 2007; 13(2): 103 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Chen, H.-C. Kuo, C.-L. Chien, C.-T. Shun, Y.-L. Yao, P.-L. Ip, C.-Y. Chuang, C.-C. Wang, Y.-S. Yang, and H-N. Ho Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation Hum. Reprod., February 1, 2007; 22(2): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bhatia Hematopoietic Development from Human Embryonic Stem Cells Hematology, January 1, 2007; 2007(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, P. Stojkovic, S. Przyborski, M. Cooke, L. Armstrong, M. Lako, and M. Stojkovic Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos Stem Cells, December 1, 2006; 24(12): 2669 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ellerstrom, R. Strehl, K. Moya, K. Andersson, C. Bergh, K. Lundin, J. Hyllner, and H. Semb Derivation of a Xeno-Free Human Embryonic Stem Cell Line Stem Cells, October 1, 2006; 24(10): 2170 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Civin and M. S. Rao How Many Human Embryonic Stem Cell Lines Are Sufficient? A U.S. Perspective Stem Cells, April 1, 2006; 24(4): 800 - 803. [Full Text] [PDF] |
||||
![]() |
S. K. Oh, H. S. Kim, Y. B. Park, H. W. Seol, Y. Y. Kim, M. S. Cho, S. Y. Ku, Y. M. Choi, D.-W. Kim, and S. Y. Moon Methods for Expansion of Human Embryonic Stem Cells Stem Cells, May 1, 2005; 23(5): 605 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stojkovic, M. Lako, T. Strachan, and A. Murdoch Derivation, growth and applications of human embryonic stem cells Reproduction, September 1, 2004; 128(3): 259 - 267. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||












